• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, October 13, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Acceptance of first non-animal method by China FDA anticipated

Bioengineer by Bioengineer
November 2, 2016
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

GAITHERSBURG, MD – November 2, 2016 – The Institute for In Vitro Sciences (IIVS) welcomes the news from China Food and Drug Administration (CFDA) officials that – for the first time in China – data from a non-animal test method will soon be recognized for safety evaluations of cosmetics.

The method, known as the 3T3 Phototoxicity assay, measures a chemical's potential to cause harm after exposure to light. The test has undergone formal validation internationally and has been incorporated into the OECD Test Guideline program (OECD TG #432). A subsequent inter-laboratory evaluation of the test was conducted in China with input from IIVS. Once the method is officially published by CFDA, it can be used to substantiate the safety of cosmetics, personal care products, and their ingredients.

"The anticipated publication by CFDA is an extremely important step for China" says Erin Hill, Co-Founder and President of IIVS. "It clearly demonstrates China's commitment to modernize their testing requirements and reduce their reliance on animal models".

IIVS and CFDA/National Institute for Food and Drug Control (NIFDC), which has regulatory authority over cosmetics in China, have been working together for several years under a Memorandum of Understanding (MOU) for scientific exchange around the use of non-animal (in vitro) methods for safety assessments. A key component of the MOU is an annual hands-on training provided by IIVS to national and provincial Institute for Food and Drug Control scientists. Over the past four years, approximately 400 regulatory scientists have been trained in methods such as phototoxicity, skin and eye irritation and skin sensitization. IIVS, together with NIFDC, is currently holding its 4th annual training at the laboratory facility of the Zhejiang Institute for Food and Drug control in Hangzhou, China.

IIVS Educational and Outreach programs are made possible by funding provided by its Industry Council for the Advancement of Regulatory Acceptance of Alternatives (ICARAA), other individual companies and animal protection organizations such as PETA.

About IIVS IIVS is a non-profit organization wholly dedicated to the promotion of rapid and innovative non-animal test methods Founded in 1997, IIVS is recognized as a leading provider of in vitro testing in support of toxicological safety evaluations. Rigorous scientific programs coupled with educational and outreach initiatives have established IIVS as a global leader in the advancement of alternatives to animal testing. For more information, visit http://www.iivs.org.

###

Media Contact

Laura Henning
[email protected]
301-758-6078
@the_iivs

Home

Share12Tweet7Share2ShareShareShare1

Related Posts

blank

Revolutionizing Signal Processing: The Traveling-Wave Amplifier

October 13, 2025

Mobile Health Boosts Clinic Attendance for HIV Patients

October 13, 2025

Discover Mutactimycins H-J: Antimycobacterial Treasures Uncovered!

October 13, 2025

New Lung-on-a-Chip Model Simulates Severe Influenza

October 13, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1234 shares
    Share 493 Tweet 308
  • New Study Reveals the Science Behind Exercise and Weight Loss

    104 shares
    Share 42 Tweet 26
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    101 shares
    Share 40 Tweet 25
  • Revolutionizing Optimization: Deep Learning for Complex Systems

    91 shares
    Share 36 Tweet 23

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Revolutionizing Signal Processing: The Traveling-Wave Amplifier

Mobile Health Boosts Clinic Attendance for HIV Patients

Discover Mutactimycins H-J: Antimycobacterial Treasures Uncovered!

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 64 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.